Cargando…

Zn(II)-phthalocyanine as a photodynamic agent for tumours. II. Studies on the mechanism of photosensitised tumour necrosis.

The mechanism of tumour necrosis photosensitised by liposome-delivered Zn(II) phthalocyanine (Zn-Pc) has been studied in mice bearing a transplanted MS-2 fibrosarcoma. Ultrastructural analyses of tumour specimens obtained at different times after red light-irradiation (300 J cm-2, dose-rate 180 mW c...

Descripción completa

Detalles Bibliográficos
Autores principales:	Milanesi, C., Zhou, C., Biolo, R., Jori, G.
Formato:	Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 1990
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1971696/ https://www.ncbi.nlm.nih.gov/pubmed/2372486

Ejemplares similares

Liposome- or LDL-administered Zn (II)-phthalocyanine as a photodynamic agent for tumours. I. Pharmacokinetic properties and phototherapeutic efficiency.
por: Reddi, E., et al.
Publicado: (1990)

Tumour-localising and -photosensitising properties of a novel zinc(II) octadecylphthalocyanine.
por: Ometto, C., et al.
Publicado: (1996)

Pharmacokinetic studies with zinc(II)-phthalocyanine in tumour-bearing mice.
por: Reddi, E., et al.
Publicado: (1987)

Effect of axial ligation and delivery system on the tumour-localising and -photosensitising properties of Ge(IV)-octabutoxy-phthalocyanines.
por: Soncin, M., et al.
Publicado: (1995)

CGP 55398, a liposomal Ge(IV) phthalocyanine bearing two axially ligated cholesterol moieties: a new potential agent for photodynamic therapy of tumours.
por: Segalla, A., et al.
Publicado: (1994)

The photodynamic response of two rodent tumour models to four zinc (II)-substituted phthalocyanines.
por: Cruse-Sawyer, J. E., et al.
Publicado: (1998)

Photodynamic therapy of melanoma using new, synthetic porphyrins and phthalocyanines as photosensitisers – a comparative study
por: BALDEA, IOANA, et al.
Publicado: (2015)

Improved Photodynamic Efficacy of Zn(II) Phthalocyanines via Glycerol Substitution
por: Chin, Yunni, et al.
Publicado: (2014)

Photodynamic therapy on the normal rabbit larynx with phthalocyanine and 5-aminolaevulinic acid induced protoporphyrin IX photosensitisation.
por: Kleemann, D., et al.
Publicado: (1996)

Photodynamic therapy of normal rat arteries after photosensitisation using disulphonated aluminium phthalocyanine and 5-aminolaevulinic acid.
por: Grant, W. E., et al.
Publicado: (1994)

Selectivity of the photosensitiser Tookad® for photodynamic therapy evaluated in the Syrian golden hamster cheek pouch tumour model
por: Borle, F, et al.
Publicado: (2003)

Syntheses and Photodynamic Activity of Pegylated Cationic Zn(II)-Phthalocyanines in HEp2 Cells
por: Ongarora, Benson G., et al.
Publicado: (2012)

Cobalamin (Vitamin B12) in Anticancer Photodynamic Therapy with Zn(II) Phthalocyanines
por: Mantareva, Vanya, et al.
Publicado: (2023)

Photodynamic Inactivation of Antibiotic-Resistant and Sensitive Aeromonas hydrophila with Peripheral Pd(II)- vs. Zn(II)-Phthalocyanines
por: Mantareva, Vanya N., et al.
Publicado: (2022)

Cellular levels of photosensitisers in tumours: the role of proximity to the blood supply.
por: Korbelik, M., et al.
Publicado: (1994)

Photodynamic Therapy and the Development of Metal-Based Photosensitisers
por: Josefsen, Leanne B., et al.
Publicado: (2008)

Serum albumin as a vehicle for zinc phthalocyanine: photodynamic activities in solid tumour models.
por: Larroque, C., et al.
Publicado: (1996)

Selective photodynamic inactivation of a multidrug transporter by a cationic photosensitising agent.
por: Kessel, D., et al.
Publicado: (1995)

Hexadecafluorinated zinc phthalocyanine: photodynamic properties against the EMT-6 tumour in mice and pharmacokinetics using 65Zn as a radiotracer.
por: Boyle, R. W., et al.
Publicado: (1996)

Tumour-localising and -photosensitizing properties of liposome-delivered Ge(IV)-octabutoxy-phthalocyanine.
por: Cuomo, V., et al.
Publicado: (1991)

Mechanisms for optimising photodynamic therapy: second-generation photosensitisers in combination with mitomycin C.
por: van Geel, I. P., et al.
Publicado: (1995)

ALA and ALA hexyl ester in free and liposomal formulations for the photosensitisation of tumour organ cultures
por: Casas, A, et al.
Publicado: (2002)

Pegylation of charged polymer-photosensitiser conjugates: effects on photodynamic efficacy
por: Hamblin, M R, et al.
Publicado: (2003)

Mechanism of the Zn(II)Phthalocyanines’ Photochemical Reactions Depending on the Number of Substituents and Geometry
por: Zucolotto Cocca, Leandro Henrique, et al.
Publicado: (2016)

Water-soluble aluminium phthalocyanine–polymer conjugates for PDT: photodynamic activities and pharmacokinetics in tumour-bearing mice
por: Brasseur, N, et al.
Publicado: (1999)

Assessing Amphiphilic ABAB Zn(II) Phthalocyanines with Enhanced Photosensitization Abilities in In Vitro Photodynamic Therapy Studies Against Cancer
por: Revuelta-Maza, Miguel Á., et al.
Publicado: (2020)

Symmetrically Substituted Zn and Al Phthalocyanines and Polymers for Photodynamic Therapy Application
por: Prabhu C. P., Keshavananda, et al.
Publicado: (2021)

Combination of Two Photosensitisers in Anticancer, Antimicrobial and Upconversion Photodynamic Therapy
por: Mušković, Martina, et al.
Publicado: (2023)

In vivo fluorescence and photodynamic activity of zinc phthalocyanine administered in liposomes.
por: van Leengoed, H. L., et al.
Publicado: (1994)

Photosensitising potency of structural analogues of benzoporphyrin derivative (BPD) in a mouse tumour model.
por: Richter, A. M., et al.
Publicado: (1991)

Synthesis and biological evaluation of an epidermal growth factor receptor-targeted peptide-conjugated phthalocyanine-based photosensitiser
por: Xue, Evelyn Y., et al.
Publicado: (2019)

Specific targeting and toxicity of sulphonated aluminium phthalocyanine photosensitised liposomes directed to cells by monoclonal antibody in vitro.
por: Morgan, J., et al.
Publicado: (1989)

meso-Tetra(hydroxyphenyl)porphyrins, a new class of potent tumour photosensitisers with favourable selectivity.
por: Berenbaum, M. C., et al.
Publicado: (1986)

Tumour-necrosis factor from the rabbit. II. Production by monocytes.
por: Matthews, N.
Publicado: (1978)

Preparation and In Vitro Photodynamic Activity of Glucosylated Zinc(II) Phthalocyanines as Underlying Targeting Photosensitizers
por: Liu, Jian-Yong, et al.
Publicado: (2017)

Utilisation of Targeted Nanoparticle Photosensitiser Drug Delivery Systems for the Enhancement of Photodynamic Therapy
por: Kruger, Cherie Ann, et al.
Publicado: (2018)

Polymorphism in the tumour necrosis factor receptor II gene is associated with circulating levels of soluble tumour necrosis factor receptors in rheumatoid arthritis
por: Glossop, John R, et al.
Publicado: (2005)

Calcium-dependent photodynamic action of di- and tetrasulphonated aluminium phthalocyanine on normal and tumour-derived rat pancreatic exocrine cells.
por: al-Laith, M., et al.
Publicado: (1994)

Cell Death Pathways and Phthalocyanine as an Efficient Agent for Photodynamic Cancer Therapy
por: Mfouo-Tynga, Ivan, et al.
Publicado: (2015)

Ru(ii)/Os(ii)-based carbonic anhydrase inhibitors as photodynamic therapy photosensitizers for the treatment of hypoxic tumours
por: Wang, Youchao, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_rcjq8isabs1e4cf4v53rmuondg